SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002458
Filing Date
2023-02-14
Accepted
2023-02-14 16:46:13
Documents
1
Period of Report
2023-02-10

Document Format Files

Seq Description Document Type Size
1 form4-02142023_040248.html 4  
1 form4-02142023_040248.xml 4 3948
  Complete submission text file 0001415889-23-002458.txt   5386
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Laccona Nicholas (Reporting) CIK: 0001886497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 23630775